Optio Rx

Nashville, United States Founded: 2018 • Age: 8 yrs
Provider of drug compounding and patient consultation services

About Optio Rx

Optio Rx is a Healthcare company based in Nashville (United States) founded in 2018. Provider of drug compounding and patient consultation services. Its focus areas include Services for Healthcare Providers, BPO, Outsourced Clinical Services and Drug Compounding. Its competitors include Fagron, Revelation Pharma and Syntis; 1 of its 3 listed competitors has raised funding.

Company details

Optio Rx provider of drug compounding and patient consultation services through providing healthcare solutions, services for healthcare providers, bpo, outsourced clinical services, and drug compounding. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Nashville, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website optiorx.com
Key Metrics

Funding Insights of Optio Rx

  • Total Rounds 2
  • Investors Count 1

All 2 funding rounds of Optio Rx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2018Debt – Conventional––
Jul 2018Seed––
Valuation history

1 investors in total: 1 institutional.

Investors in Optio Rx

Optio Rx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Capitala Group.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Global multi-sector investments are managed by the private equity firm.
capitalagroup.comCharlotte, United States
Premium access

Investor details for Optio Rx

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Optio Rx

5 people are tracked at Optio Rx (2 in leadership, 3 in team).

NameRoleGroup
Robert Stricklin, M.B.A.
Director of Financial Planning and AnalysisLeadership
Leo LaFranco
Chief Financial OfficerLeadership
Jon Finch
Member - Board Of DirectorsTeam
Vincent Schettino
OptioRx Territory Sales RepresentativeTeam
Matt Goller
Business Development ManagerTeam
Premium access

Complete people profiles for Optio Rx

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Optio Rx

2 dated milestones of Optio Rx, from founding to its latest funding, stage changes and deals.

  1. Founded Optio Rx is founded.
  2. Funding First funding round.

Competitors of Optio Rx

Optio Rx has 3 listed competitors in our database, 1 of them funded. They include Fagron, Revelation Pharma and Syntis.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
fagron.com1990Saint Paul, United States3,315
Drug compounding services are provided by Fagron.
revcustomrx.com2020Greenwood Village, United States
A network of compounding pharmacies is operated nationwide.
syntis.bio2021Boston, United States$65.88M
Drug compounding services are provided by Syntis in healthcare.
Premium access

Detailed competitors of Optio Rx

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Optio Rx

The website of Optio Rx (optiorx.com) receives about 3.3K visits a month.

  • Monthly visits
    3.3K

    ▼ 52.7% vs previous month

Top companies in Healthcare Provider Support Services

3 companies that operate in the same segment as Optio Rx (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of self funded health plan
2017New York, New York, United StatesUSD 224 M212
Provider of AI solutions for clinical, operational, and business outcomes
2005Princeton, New Jersey, United StatesUSD 1.13 BUSD 465.22 M5,442
AMN Healthcare is recognized as a leading healthcare staffing provider.
1985San Diego, California, United StatesUSD 2.73 B2,970
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Optio Rx

Optio Rx was founded in 2018.

Optio Rx is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.

Optio Rx provider of drug compounding and patient consultation services through providing healthcare solutions, services for healthcare providers, bpo, outsourced clinical services, and drug compounding. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Optio Rx's top competitors include Syntis, Fagron and Revelation Pharma.

Optio Rx has 1 investor. Key investors include Capitala Group.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available